Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

NEW ORLEANS — For contrast-enhanced imaging in multiple sclerosis (MS), all gadolinium-based agents accumulate in body tissue but to greatly varying degrees. While the long-term effect of gadolinium ...

Gadolinium-enhanced MRI is associated with an increased risk of stillbirth or neonatal death, as well as rheumatologic, inflammatory, or infiltrative skin conditions. MRI use in the first trimester of ...

After adjusting for gender, age, education level, baseline neurocognitive performance, and others, the authors reported gadolinium exposure was not a significant predictor of cognitive decline, ...

There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive decline, according to a new study. There is no evidence that accumulation in the brain of the element ...

Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...

Study Overview: This ongoing Phase 4 study, officially titled “Prospective Evaluation of Potential Effects of Repeated Gadolinium-based Contrast Agent (GBCA) Administrations of the Same GBCA on Motor ...

A medical innovation that has significantly advanced medical treatments, magnetic resonance imaging has helped doctors see inside the body. MRI scans are a non-invasive and relatively safe procedure.

Marignac first isolated gadolinia, an oxide of gadolinium (Gd), in 1880. Then, in 1886, Lecoq de Boisbaudran successfully separated the element from Mosander’s “yttria.” Gadolinium is present in ...

Nanoscientists have demonstrated a method for loading nanoparticles with iron ions to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing ...